New fragmentome technology can detect early liver fibrosis and cirrhosis
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free…
Common cardio drugs proven safe in myeloma patients
Commonly prescribed cardiovascular medications—such as statins, diuretics, and blood pressure drugs—appear to have little or no negative impact…
Grandad with brain cancer thought headaches were sleep apnea | Health
A grandad who put his headaches and fatigue down to sleep apnoea was diagnosed with aggressive brain cancer.…
Assessing long-term cognitive risks in ependymoma survivors
A study led by St. Jude Children’s Research Hospital assessed cognitive and communication abilities in children treated for…
Stilbenoid gaylussacin modulates particulate matter-induced chromatin remodeling in macrophages to suppress chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD), a leading cause of mortality worldwide, is characterized by chronic bronchitis and emphysema.1…
Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology
Competing interests S.F. reports research support from Abbisko, Antengene, BeiGene, BeyongSpring Pharmaceuticals, BioAtla, Boehringer Ingelheim, CUE Biopharma, DEKA…
Crick spin‑out ALTx will target cancer cell immortality
Founded in late 2024, ALTx Therapeutics has come out of stealth mode with plans to develop therapies…
Reprogrammed neutrophils promote tumor growth
Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE)…
Study shows DHPS enzyme controls macrophage maturation across multiple organs
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns…
Web-based cytometry atlas reveals immune signatures across pancreatic cancer treatments
Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of vaccines and…
JPM26: J&J reveals oncology strategy
CEO Joaquin Duato presented a strong outlook for Johnson & Johnson’s (J&J) revenue growth in 2026, with particular…
Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trial
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a…